S Sebastian1,2, S Myers3, S Nadir3, S Subramanian4. 1. IBD Unit, Hull and East Yorkshire NHS Trust, Hull, UK. shaji.sebastian@hey.nhs.uk. 2. Hull York Medical School, Hull, UK. shaji.sebastian@hey.nhs.uk. 3. IBD Unit, Hull and East Yorkshire NHS Trust, Hull, UK. 4. The Royal Liverpool and Broad Green University Hospitals NHS Foundation Trust, Liverpool, UK.
Abstract
BACKGROUND: Pharmacokinetic data suggest that standard induction dosing schedules may not be sufficient in patients with acute severe colitis (ASUC). Hence, intensified induction regimes are increasingly used in the rescue treatment of hospitalized patients with ASUC to avoid the need for colectomy although the evidence for this is uncertain. AIM: To conduct a systematic review of short- and long-term efficacy outcomes from accelerated infliximab induction studies. METHODS: Systematic search of relevant databases (MEDLINE, EMBASE, Cochrane Database of Systematic Reviews) and relevant conference proceedings (Digestive Diseases Week, European Colitis and Crohn's Organisation Congress, United European Gastroenterology Week) was done. RESULTS: We identified ten relevant studies with a total of 705 patients, of whom 308 received an intensified infliximab regime. Pooled analysis showed no difference in short-term or long-term colectomy rates in those receiving accelerated induction regimes when compared to standard induction. No significant differences in complication rates were identified. CONCLUSIONS: The available uncontrolled studies so far do not suggest short-term or long-term benefit in using accelerated induction in hospitalized ASUC. The overall poor quality of available studies with confounding variables indicates the need for a randomized controlled trial with personalized risk stratification.
BACKGROUND: Pharmacokinetic data suggest that standard induction dosing schedules may not be sufficient in patients with acute severe colitis (ASUC). Hence, intensified induction regimes are increasingly used in the rescue treatment of hospitalized patients with ASUC to avoid the need for colectomy although the evidence for this is uncertain. AIM: To conduct a systematic review of short- and long-term efficacy outcomes from accelerated infliximab induction studies. METHODS: Systematic search of relevant databases (MEDLINE, EMBASE, Cochrane Database of Systematic Reviews) and relevant conference proceedings (Digestive Diseases Week, European Colitis and Crohn's Organisation Congress, United European Gastroenterology Week) was done. RESULTS: We identified ten relevant studies with a total of 705 patients, of whom 308 received an intensified infliximab regime. Pooled analysis showed no difference in short-term or long-term colectomy rates in those receiving accelerated induction regimes when compared to standard induction. No significant differences in complication rates were identified. CONCLUSIONS: The available uncontrolled studies so far do not suggest short-term or long-term benefit in using accelerated induction in hospitalized ASUC. The overall poor quality of available studies with confounding variables indicates the need for a randomized controlled trial with personalized risk stratification.
Entities:
Keywords:
Accelerated induction; Acute severe UC; Infliximab; Rescue therapy
Authors: M Chaparro; P Burgueño; E Iglesias; J Panés; F Muñoz; G Bastida; L Castro; C Jiménez; J L Mendoza; M Barreiro-de Acosta; S Gómez Senent; F Gomollón; X Calvet; E García-Planella; M Gómez; V Hernández; J Hinojosa; M Mañosa; O Pérez Nyssen; J P Gisbert Journal: Aliment Pharmacol Ther Date: 2011-12-05 Impact factor: 8.171
Authors: C W Lees; D Heys; G T Ho; C L Noble; A G Shand; C Mowat; R Boulton-Jones; A Williams; N Church; J Satsangi; I D R Arnott Journal: Aliment Pharmacol Ther Date: 2007-08-01 Impact factor: 8.171
Authors: Dan Turner; Catharine M Walsh; A Hillary Steinhart; Anne M Griffiths Journal: Clin Gastroenterol Hepatol Date: 2006-12-04 Impact factor: 11.382
Authors: Shailja C Shah; Steven Naymagon; Hinaben J Panchal; Bruce E Sands; Benjamin L Cohen; Marla C Dubinsky Journal: Inflamm Bowel Dis Date: 2018-02-15 Impact factor: 5.325
Authors: Matthew C Choy; Dean Seah; Alexandra Gorelik; Yoon-Kyo An; Cheng-Yu Chen; Finlay A Macrae; Miles P Sparrow; William R Connell; Gregory T Moore; Graham Radford-Smith; Daniel R Van Langenberg; Peter De Cruz Journal: J Gastroenterol Hepatol Date: 2018-02-27 Impact factor: 4.029
Authors: Gert Van Assche; Geert D'Haens; Maja Noman; Séverine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts Journal: Gastroenterology Date: 2003-10 Impact factor: 22.682
Authors: S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer Journal: N Engl J Med Date: 1994-06-30 Impact factor: 91.245
Authors: David Laharie; Arnaud Bourreille; Julien Branche; Matthieu Allez; Yoram Bouhnik; Jerome Filippi; Frank Zerbib; Guillaume Savoye; Maria Nachury; Jacques Moreau; Jean-Charles Delchier; Jacques Cosnes; Elena Ricart; Olivier Dewit; Antonio Lopez-Sanroman; Jean-Louis Dupas; Franck Carbonnel; Gilles Bommelaer; Benoit Coffin; Xavier Roblin; Gert Van Assche; Maria Esteve; Martti Färkkilä; Javier P Gisbert; Philippe Marteau; Stephane Nahon; Martine de Vos; Denis Franchimont; Jean-Yves Mary; Jean-Frederic Colombel; Marc Lémann Journal: Lancet Date: 2012-10-10 Impact factor: 79.321
Authors: Shaji Sebastian; Jessica Lisle; Sreedhar Subramanian; Anjan Dhar; Achut Shenoy; Jimmy Limdi; Jeffrey Butterworth; Patrick B Allen; Sunil Samuel; Gordon Moran; Richard Shenderey; Gareth Parkes; Tim Raine; Alan J Lobo; Nicholas A Kennedy Journal: Frontline Gastroenterol Date: 2019-08-17
Authors: Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi Journal: World J Gastroenterol Date: 2020-11-21 Impact factor: 5.742
Authors: Shaji Sebastian; Gareth J Walker; Nicholas A Kennedy; Thomas E Conley; Kamal V Patel; Sreedhar Subramanian; Alexandra J Kent; Jonathan P Segal; Matthew J Brookes; Neeraj Bhala; Haidee A Gonzalez; Lucy C Hicks; Shameer J Mehta; Christopher A Lamb Journal: Lancet Gastroenterol Hepatol Date: 2021-02-02